NEW YORK (Reuters Health) Oct 01 - Maraviroc reduces viral load and improves CD4 cell counts when added to optimized background therapy in treatment-experienced patients infected with R5 HIV-1, according to the results of two multinational phase III clinical trials reported in the October 2 issue of The New England Journal of Medicine.

Read the rest of this entry »

NEW YORK (Reuters Health) Oct 01 - Serious toxicity appears to be associated with continuous nevirapine-based highly active antiretroviral therapy (HAART) in HIV-positive pregnant women, according to Canadian researchers.

Read the rest of this entry »

NEW YORK (Reuters Health) Oct 02 - Progressive multifocal leukoencephalopathy (PML) “continues to be one of the deadliest opportunistic infections in acquired immunodeficiency syndrome patients,” Spanish investigators report in the September 1 issue of the Journal of Acquired Immune Deficiency Syndromes.

Read the rest of this entry »

NEW YORK (Reuters Health) Oct 02 - The US Centers for Disease Control and Prevention estimate that approximately 1.1 million adults and adolescents in the US were living with HIV infection at the end of 2006, according to an article in the Morbidity and Mortality Weekly Report for October 3.

Read the rest of this entry »

PRETORIA (Reuters) Oct 02 - South Africa’s new health minister Barbara Hogan vowed on Thursday to make AIDS a top priority, after years of controversy over her predecessor’s unconventional support for treatments like beetroot and garlic.

Read the rest of this entry »

NEW YORK (Reuters Health) Sept 29 - High suicidal ideation rates persist among HIV-positive patients despite treatment advances, according to a report by UK researchers in the August 20th issue of AIDS.

Read the rest of this entry »